3,4-dihydroxybenzohydroxamic acid has been researched along with Acquired Immune Deficiency Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mayhew, CN | 1 |
Phillips, JD | 1 |
Greenberg, RN | 1 |
Birch, NJ | 1 |
Elford, HL | 1 |
Gallicchio, VS | 1 |
2 other studies available for 3,4-dihydroxybenzohydroxamic acid and Acquired Immune Deficiency Syndrome
Article | Year |
---|---|
Drug targets cellular enzyme.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Benzamidines; Disease Models, Animal; | 1999 |
In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Animals; Anti-HIV Agents; Benzamidines; Cells, Cultured; | 1999 |